论文部分内容阅读
我所是属于综合性医院领导下的结防所,病例发现工作主要由各科转诊而来(占90％),其次是通过各类体检发现。菌阳病例占每年新登的1/3左右。逐年误诊率分别为:2.67％,2.35％,1.90％,1.32％,4.3％,4.0％。新登记中80％为初治病例,复治占20％左右。新登记与登记病例比例由1980年0.28％到1985年上升到0.92％。初治菌阳新登记病例一年痰菌阴转率均在95％以上。我们于1960年起建立了防痨网,于1979年7月起开展了全程化疗管理,主要对象为新登记的活动性肺结核及复治菌阳病人。新登记患者管理覆盖率达到90％以上。自1979年以来逐步开展了短程化疗,至1984年已对全部新登记病人实施了短程化疗,使初治新登记菌阳病人年痰菌阴转率达95％以上,取得了显著疗效,
I belong to the general hospital under the leadership of the anti-tuberculosis clinic, cases found mainly by the subjects referral (90%), followed by various types of physical examination found. Yang bacteria cases accounted for about 1/3 of the new board. Year-by-year misdiagnosis rates were: 2.67%, 2.35%, 1.90%, 1.32%, 4.3%, 4.0%. 80% of newly registered cases of newly diagnosed cases, retreatment accounted for about 20%. The ratio of new registrations to registered cases rose from 0.28% in 1980 to 0.92% in 1985. Newly diagnosed bacilli new cases of sputum sputum negative conversion rates were 95% or more. We established the anti-tuberculosis network in 1960 and conducted full-scale chemotherapy management since July 1979. The main targets are newly registered active tuberculosis and retreatment patients. Newly registered patients management coverage of more than 90%. Since 1979, short-course chemotherapy has been gradually carried out. By 1984, all newly-registered patients have undergone short-course chemotherapy, which has achieved over 95% annual sputum negative conversion rate in the newly-diagnosed bacillary patients with newly diagnosed disease, and achieved remarkable curative effect.